MAPK9 and cancer: Finally, the involvement of AKT, SMAD2, SAPK/JNK, survivin, and protein stability, evidenced in this study, could converge in ROS-inducing pathways (e.g., Nuclear factor erythroid-derived 2, NRF2) to increase NGB levels and, ultimately, to cancer cell survival.